What is Pristine Surgical?
Pristine Surgical LLC operates at the intersection of advanced engineering and clinical necessity, specializing in the development of single-use surgical visualization systems. By eliminating the complexities associated with traditional reusable endoscopes, the company addresses critical pain points in hospital workflows, including sterilization bottlenecks and equipment maintenance costs. Their platform is engineered to enhance surgical precision while maintaining a high standard of patient safety, effectively disrupting the legacy medical device market. Through a focus on high-fidelity imaging and ergonomic design, Pristine Surgical provides healthcare providers with the tools necessary to improve procedural outcomes and streamline surgical throughput.
How much funding has Pristine Surgical raised?
Pristine Surgical has raised a total of $33M across 2 funding rounds:
Series B
$18M
Series D
$15M
Series B (2020): $18M, investors not publicly disclosed
Series D (2022): $15M led by Ceros Capital Markets
Key Investors in Pristine Surgical
Ceros Capital Markets
Ceros Capital Markets is a global investing platform that specializes in fundraising for MedTech and Biotech companies, focusing on disruptive technologies in medical devices, robotics, and digital health.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Pristine Surgical?
With the successful closure of this latest funding round, Pristine Surgical is well-positioned to accelerate its commercial expansion and deepen its research and development initiatives. The strategic allocation of these funds will likely focus on scaling manufacturing capabilities to meet rising demand and expanding the company's footprint in key international markets. Furthermore, the firm is expected to leverage this financial backing to enhance its product pipeline, potentially integrating advanced digital health features that further differentiate its visualization technology. As the company transitions into its next phase of growth, the focus will remain on solidifying its market share and establishing new benchmarks for efficacy in the single-use surgical device sector.
See full Pristine Surgical company page
